Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 169

The DOI matches its Crossref record.

Autoantibodies Against Oxidatively Modified Low-Density Lipoproteins in NIDDM

Bellomo, Giorgio, Maggi, Elena, Poli, Maurizio, Agosta, Fulvia G, Bollati, Paola, Finardi, Giorgio · 1995 · Diabetes

Abstract

Diabetes is an independent risk factor in the development of atherosclerosis, although the pathophysiological processes underlying this association are poorly understood. The oxidation of low-density lipoprotein (LDL) is considered a key event in the development and progression of atherosclerosis because it generates molecular epitopes that are more atherogenic than parent LDL. A total of 138 patients suffering from non-insulin-dependent diabetes mellitus (NIDDM) and 80 matched control subjects were investigated. LDL oxidation was evaluated as the presence of autoantibodies against oxidatively modified LDL, since they mirror the in vivo occurrence of oxidative processes. NIDDM patients had an antibody ratio (calculated as the ratio of antibodies against modified versus native LDL) significantly higher than control subjects for Cu2+-oxidized LDL (1.88 ± 0.6 vs. 1.05 ± 0.3, P < 0.01, for IgG), malondialdehyde-modified LDL (2.54 ± 0.73 vs. 2.04 ± 0.11, P < 0.01, for IgG and 3.96 ± 1.51 vs. 2.90 ± 0.15, P < 0.01, for IgM), and malondialdehyde-modified human serum albumin (1.79 ± 0.54 vs. 1.46 ± 0.1, P < 0.05 for IgG). The possible role played by glycation in sensitizing LDL to oxidation was investigated by measuring autoantibodies against both glycated LDL (glycLDL) and glycoxydated LDL (glycoxLDL). NIDDM patients had an antibody ratio significantly higher than control subjects for anti-glycLDL and anti-glycoxLDL IgG (1.79 ± 0.38 vs. 1.12 ± 0.23, P < 0.01 and 2.55 ± 1.03 vs. 1.39 ± 0.44, P < 0.01, respectively) but not anti-glycLDL and anti-glycox-LDL IgM. These results demonstrate that in NIDDM patients enhanced LDL oxidation occurs in vivo and that LDL glycation may represent a predisposing event that facilitates subsequent oxidative modifications.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/diab.44.1.60

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 169

Metadata

Authors
Bellomo, G., Maggi, E., Poli, M., Agosta, F. G., Bollati, P., & Finardi, G.
Venue
Diabetes
Published
1995-01-01
Volume
44
Issue
1
Pages
60-66
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W1988346971
Cited by
169
References
0
FWCI
5.96
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Autoantibodies Against Oxidatively Modified Low-Density Lipoproteins in NIDDM. https://app.cochat.ai/papers/10.2337/diab.44.1.60
The paper
Bellomo, G., Maggi, E., Poli, M., Agosta, F. G., Bollati, P., & Finardi, G. (1995). Autoantibodies Against Oxidatively Modified Low-Density Lipoproteins in NIDDM. Diabetes. https://doi.org/10.2337/diab.44.1.60

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.